[18F]AlF-FAPI-74

FAPI-74 radiopharmaceutical labeled with Fluorine-18 via Aluminum-Fluoride complex · KU Leuven

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for [18F]AlF-FAPI-74, covering 2025-02-07 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA. [Phase 2, Phase 3]

See pricing